Israel is at the forefront of cancer innovation and spends roughly half its medical budget on cancer-related treatments and medicine.

Cancer treatments come at a high cost due to genetic engineering methods and custom-built chemicals.

At Sheba hospital, the Cancer Innovation Research Center is bringing down this cost and seeks to mass produce these future treatments of personalized medicines, reports i24news.

Prof. Dror Harats of Sheba Medical Center explains the challenges and the map for the future.